Journal of Infection and Public Health

Scope & Guideline

Driving Change Through Evidence-Based Public Health Studies

Introduction

Welcome to the Journal of Infection and Public Health information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Journal of Infection and Public Health, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1876-0341
PublisherELSEVIER SCIENCE LONDON
Support Open AccessYes
CountryNetherlands
TypeJournal
Convergefrom 2008 to 2024
AbbreviationJ INFECT PUBLIC HEAL / J. Infect. Public Health
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Aims and Scopes

The Journal of Infection and Public Health focuses on advancing the understanding of infectious diseases and their impact on public health. It aims to publish high-quality research on various aspects of infectious diseases, including their epidemiology, prevention, diagnosis, treatment, and management, particularly in the context of public health policies and practices.
  1. Epidemiology of Infectious Diseases:
    The journal publishes studies exploring the distribution and determinants of infectious diseases in populations, emphasizing the need for effective surveillance and intervention strategies.
  2. Emerging Infections and Outbreak Response:
    Research on emerging infectious diseases and outbreak response strategies, particularly in the context of global health security, is a core focus area, reflecting the urgent need for preparedness in public health.
  3. Antimicrobial Resistance:
    The journal addresses the growing challenge of antimicrobial resistance, publishing studies that investigate resistance mechanisms, patterns, and strategies for stewardship and management.
  4. Public Health Interventions and Policies:
    Papers that evaluate the effectiveness of public health interventions and policies aimed at controlling infectious diseases are a significant component of the journal's scope.
  5. Clinical Management of Infectious Diseases:
    Research focusing on the clinical management, treatment outcomes, and guidelines for various infectious diseases, including the role of new therapeutics and vaccination strategies, is prominently featured.
  6. Infection Prevention and Control:
    The journal emphasizes research on infection prevention and control measures within healthcare settings, aiming to improve patient safety and reduce nosocomial infections.
  7. Global Health Perspectives:
    It also seeks to incorporate global health perspectives, highlighting disparities in health outcomes and access to care across different regions and populations.
The Journal of Infection and Public Health has seen a significant evolution in its focus areas, particularly in response to recent global health challenges. Emerging themes reflect the journal's adaptive approach to contemporary public health issues and the growing complexity of infectious disease management.
  1. COVID-19 Research:
    There has been a marked increase in research related to COVID-19, covering aspects such as vaccine efficacy, long COVID, and public health responses to the pandemic.
  2. Artificial Intelligence in Disease Management:
    Emerging studies on the application of artificial intelligence and machine learning in predicting and managing infectious diseases indicate a trend towards integrating technology in public health.
  3. Mental Health Impacts of Infectious Diseases:
    Research exploring the mental health impacts of infectious diseases, particularly following the COVID-19 pandemic, is gaining traction, highlighting the intersection of mental and physical health.
  4. Vaccination Strategies and Public Acceptance:
    There is a growing emphasis on research related to vaccination strategies, public acceptance, and the social determinants influencing vaccination uptake.
  5. One Health Approach:
    The integration of the One Health approach, which considers the interconnectedness of human, animal, and environmental health, is emerging as a significant theme in recent publications.
  6. Global Health Equity:
    Studies addressing health disparities and promoting equity in access to healthcare, particularly in low- and middle-income countries, are increasingly featured.

Declining or Waning

While the Journal of Infection and Public Health has consistently focused on various important themes, certain areas of research appear to be declining in prominence based on recent publications. This shift may reflect changing priorities in the field of infectious disease research and emerging global health challenges.
  1. Traditional Infectious Diseases:
    There is a noticeable decline in research focusing on traditional infectious diseases such as tuberculosis and malaria, as recent publications have shifted more towards emerging infections and COVID-19-related studies.
  2. Non-communicable Disease Interactions:
    Research examining the interactions between infectious diseases and non-communicable diseases has decreased, potentially overshadowed by the urgency of addressing infectious disease outbreaks.
  3. Longitudinal Studies:
    Longitudinal studies on the long-term effects of infectious diseases or public health interventions seem to be less frequent, possibly due to the immediate focus on short-term pandemic responses.
  4. Single Pathogen Focus Studies:
    There appears to be a decline in studies focusing solely on single pathogens, as the journal increasingly favors research that evaluates co-infections and multi-pathogen interactions.

Similar Journals

LANCET INFECTIOUS DISEASES

Empowering Healthcare Through Rigorous Research
Publisher: ELSEVIER SCI LTDISSN: 1473-3099Frequency: 12 issues/year

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Annals of Clinical Microbiology and Antimicrobials

Connecting researchers to the latest advancements in infectious diseases.
Publisher: BMCISSN: Frequency: 1 issue/year

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.

Eurosurveillance

Advancing global health through open access research.
Publisher: EUR CENTRE DIS PREVENTION & CONTROLISSN: 1025-496XFrequency: 50 issues/year

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.

Southern African Journal of Infectious Diseases

Empowering the fight against infectious diseases in the region.
Publisher: AOSISISSN: 2312-0053Frequency: 4 issues/year

Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.

International Journal of Antimicrobial Agents

Leading the Charge in Antimicrobial Research and Development
Publisher: ELSEVIERISSN: 0924-8579Frequency: 12 issues/year

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

Journal of Infection Prevention

Empowering practitioners with evidence-based infection prevention strategies.
Publisher: SAGE PUBLICATIONS LTDISSN: 1757-1774Frequency: 6 issues/year

Journal of Infection Prevention, published by SAGE Publications Ltd, is a pivotal resource in the fields of nursing, public health, and infectious diseases. With an ISSN of 1757-1774 and an E-ISSN of 1757-1782, this journal primarily serves as a platform for disseminating innovative research and comprehensive reviews aimed at enhancing infection control practices and health policy formulation. As of 2023, it holds a prestigious position within category quartiles, ranking Q2 in Advanced and Specialized Nursing and Q3 in Health Policy, Infectious Diseases, as well as Public Health, Environmental and Occupational Health, underscoring its relevance and influence in these arenas. Researchers, practitioners, and students are encouraged to explore the journal's content to contribute to the advancement of infection prevention strategies and the overall improvement of healthcare systems. With a convergence timeline from 2009 to 2024, the Journal of Infection Prevention is committed to publishing high-quality articles that address current challenges in infection control, thus playing a crucial role in the ongoing dialogue among health professionals.

Journal of Hospital Infection

Uniting Global Expertise to Combat Hospital Infections
Publisher: W B SAUNDERS CO LTDISSN: 0195-6701Frequency: 12 issues/year

Journal of Hospital Infection, published by W B SAUNDERS CO LTD, stands as a pivotal resource in the infectious diseases, medicine, and microbiology sectors. With an impressive impact factor positioning it in the Q1 quartile across its relevant categories, this journal not only ranks highly—#32 out of 344 in Infectious Diseases and #17 out of 140 in Medical Microbiology—but also exemplifies a commitment to advancing knowledge and practice in hospital infection control. Since its inception in 1980, the journal has become a vital platform for disseminating research that informs clinical practices, promotes safety in health care environments, and enhances medical education. While access is non-open, the journal's extensive scope and rigorously peer-reviewed contributions ensure its relevance and significance to researchers, professionals, and students aiming to stay at the forefront of this dynamic field. The journal’s headquarters in London underscores its international relevance, making it an essential reference for anyone involved in combating hospital-acquired infections.

Klimik Journal

Connecting Academia and Practice for Better Health Outcomes.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 1301-143XFrequency: 4 issues/year

Klimik Journal is a pivotal publication in the fields of Infectious Diseases and Medical Microbiology, serving as a platform for researchers, clinicians, and academics to disseminate groundbreaking findings and improve health outcomes. Established in 2010 and published by DOC DESIGN INFORMATICS CO LTD, this journal is dedicated to advancing knowledge and fostering discussions around critical issues in infectious diseases and microbial research. With an ISSN of 1301-143X and an E-ISSN of 1309-1484, Klimik Journal strives to maintain high academic standards despite currently ranking in the fourth quartile in both categories according to Scopus metrics, which highlights the need for continued contributions to the field. Operating from Turkey, the journal is committed to supporting open access options, thereby ensuring wide dissemination of research findings. As it continues to bridge the gap between theory and practice, Klimik Journal is poised to become an essential resource for those looking to stay at the forefront of infectious disease research and microbiological advancements.

Emerging Microbes & Infections

Unlocking insights into emerging infections.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

EMERGING INFECTIOUS DISEASES

Leading the Charge Against Global Infectious Challenges
Publisher: CENTERS DISEASE CONTROL & PREVENTIONISSN: 1080-6040Frequency: 12 issues/year

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.